诱导高温放疗增敏高级别胶质瘤:临床经验回顾与MR引导聚焦超声的潜在作用
高级别胶质瘤(HGG)预后差且标准治疗十余年未变。本文回顾了1980至1990年代高温(HT)联合外照射放疗和间质近距离放疗的临床研究,其中一项随机对照试验显示联合治疗生存优于单纯放疗,但HT因需有创植入、难以均匀维持瘤内温度等技术后勤挑战未进入常规实践。作者提出MR引导聚焦超声(MRgFUS)作为无创经颅HT新技术,有望克服既往局限,实现HGG放疗增敏。
要点
- HT通过损伤DNA修复、增加灌注氧合和激活免疫等多机制增强放疗疗效。
- 既往随机对照试验显示HT联合RT较单纯RT改善HGG生存,但技术限制未推广。
- MRgFUS可无创经颅精准加热,有望克服既往HT联合RT的局限。
核心结论
- MRgFUS作为一种无创经颅高温技术,有潜力克服既往HT联合RT在HGG中的技术障碍,实现放疗增敏。
研究设计与样本
- 本文为叙述性综述,汇总既往HT联合外照射放疗和间质近距离放疗治疗HGG的临床结果,并讨论MRgFUS作为无创HT方法的潜力。
主要发现
- 1980至1990年代广泛评估了HT联合外照射放疗和间质近距离放疗在HGG中的应用,最终一项随机对照试验显示联合HT与RT的患者生存优于对照组。
- HT未被纳入HGG常规实践,原因包括当时需有创植入操作、难以监测和维持肿瘤组织内均匀局部升温,以及其他技术和后勤挑战。
- HT通过损伤DNA修复通路、增加肿瘤灌注/氧合和激活免疫系统等多机制增强RT疗效。
关键数值与推荐
- 一项随机对照试验显示接受联合HT和RT的HGG患者生存优于对照。
临床怎么用
- 既往HT联合RT的临床证据支持高温可增敏HGG放疗,但受限于有创植入和温度均匀性控制难题。
- MRgFUS作为相对较新的临床技术,可实现高精度经颅HT,可能使无创HT放疗增敏成为可行方向。
局限性
- 既往HT因需有创植入、难以监测和维持肿瘤内均匀局部升温以及技术和后勤挑战而未被常规采用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-grade gliomas (HGGs) are aggressive primary brain tumors that confer poor prognoses. Despite aggressive combined modality treatment, HGGs invariably recur. Considerable research efforts and resources have focused on identification of novel therapies for HGGs; however, standard treatments have not changed significantly in more than 10 years, since the introduction of concurrent chemoradiation therapy with temozolomide. Hyperthermia (HT) has been shown to enhance the efficacy of radiation treatment (RT) in numerous cancer types through multiple mechanisms, including impairment of DNA repair pathways, increased perfusion/oxygenation of tumors, and immune system activation. In the 1980s and 1990s, the combination of HT with external-beam RT and interstitial brachytherapy was extensively evaluated in HGG, culminating in a randomized controlled trial that demonstrated superior survival in patients receiving combined HT and RT. However, HT was not adopted into common practice for HGG because of the need at that time for invasive implantation procedures, challenges to monitoring and maintaining a homogeneous, localized temperature elevation within the tumor tissue, as well as other technical and logistic challenges. Magnetic resonance imaging-guided focused ultrasound (MRgFUS) is a relatively new technology in clinical use that is capable of highly accurate transcranial HT and has the potential to overcome many of the limitations faced in previous trials combining HT and RT in HGG. In this review, we detail and compile the previous clinical results of combined HT and RT in HGG patients. We also introduce and discuss the potential of MRgFUS as a noninvasive method for HT to radiosensitize HGG.
引用
- Schneider CS, Woodworth GF, Vujaskovic Z, et al. Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound. Radiother Oncol. 2019. PMID: 31431370. doi:10.1016/j.radonc.2019.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。